U.S., Jan. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07340047) titled 'H1ssF Flu Vaccine Clinical Trial' on Dec. 09, 2025.
Brief Summary: This is a two-arm, open-label, randomized, phase 1, controlled clinical trial intended to evaluate the safety and immunologic response to the experimental vaccine H1ssF (H1 stabilized stem ferritin nanoparticle) and the seasonal flu vaccine Flucelvax.
Study Start Date: Feb. 01
Study Type: INTERVENTIONAL
Condition:
Influenza
Intervention:
BIOLOGICAL: H1ssF vaccine
Experimental influenza vaccine
BIOLOGICAL: Flucelvax seasonal vaccine
Licensed influenza vaccine
Recruitment Status: NOT_YET_RECRUITING
Sponsor: University of Minnesota
Disclaimer: Curated by HT ...